Research stack

CJC-1295 DAC Sustained GH Elevation Protocol

Long-acting GHRH analog protocol using drug affinity complex (DAC) modification for weekly dosing.

Component peptides

A growth-hormone-releasing hormone (GHRH) analogue with a maleimide (Drug Affinity Complex) linker that binds serum albumin, extending its circulating half-life to several days.

Goal

Long-acting GHRH-analog protocol using DAC-modified CJC-1295 for weekly sustained GH elevation.

Peptides

CJC-1295 DAC

Why it works

DAC modification covalently binds CJC-1295 to serum albumin, extending its half-life to roughly a week and producing sustained GH and IGF-1 elevation rather than preserving pulsatility.

How to use

CJC-1295 DAC — 1-2 mg once weekly subcutaneous.

Last updated: 2026-09-15

Component peptides	CJC-1295 with DAC
Duration reported	12 weeks
Cycle pattern	12 weeks on, 4 weeks off
Difficulty	intermediate
Regulatory status	Research use only. None of these compounds is FDA-approved for combined use described.

Peptide Codex Assistant

Research-literature companion

Hello. Ask me about a peptide, a stack, or a research protocol on Peptide Codex.

0 / 20 questions used todayResearch use only. Not medical advice.